Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.580
-0.020 (-0.77%)
Sep 2, 2026, 11:04 AM EDT - Market open
Genelux Employees
As of December 31, 2025, Genelux had 26 total employees, including 25 full-time and 1 part-time employees. The number of employees increased by 2 or 8.33% compared to the previous year.
Employees
26
Change
2
Growth
8.33%
Revenue / Employee
$308
Profits / Employee
-$1,369,077
Market Cap
115.61M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 26 | 2 | 8.33% | 25 | 1 |
| Mar 31, 2025 | 24 | 1 | 4.35% | 24 | 0 |
| Dec 31, 2024 | 24 | 1 | 4.35% | 24 | 0 |
| Sep 30, 2024 | 25 | 3 | 13.64% | 25 | 0 |
| Jun 30, 2024 | 24 | 4 | 20.00% | 24 | 0 |
| Mar 31, 2024 | 23 | 8 | 53.33% | 23 | 0 |
| Dec 31, 2023 | 23 | 8 | 53.33% | 23 | 0 |
| Sep 30, 2023 | 22 | 7 | 46.67% | 22 | 0 |
| Jun 30, 2023 | 20 | 6 | 42.86% | 20 | 0 |
| Mar 31, 2023 | 15 | 1 | 7.14% | 15 | 0 |
| Dec 31, 2022 | 15 | 1 | 7.14% | 15 | 0 |
| Sep 30, 2022 | 15 | - | - | 15 | 0 |
| Jun 30, 2022 | 14 | 1 | 7.69% | 14 | 0 |
| Mar 31, 2022 | 14 | 1 | 7.69% | 14 | 0 |
| Mar 31, 2021 | 13 | - | - | 13 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Nautilus Biotechnology | 127 |
| Cibus | 118 |
| Fractyl Health | 100 |
| enGene Therapeutics | 82 |
| Rani Therapeutics Holdings | 71 |
| Vivani Medical | 42 |
| Black Diamond Therapeutics | 21 |
| ProMIS Neurosciences | 11 |
GNLX News
- 17 days ago - Genelux reports Q2 EPS (21c), consensus (20c) - TheFly
- 17 days ago - Genelux expects cash to fund operations into Q1 of 2027 - TheFly
- 17 days ago - Genelux reports Q2 EPS (21c), consensus (20c) - TheFly
- 19 days ago - Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates - GlobeNewsWire
- 20 days ago - Genelux Quarterly report: Q2 2026 - Filings
- 20 days ago - Genelux Earnings release: Q2 2026 - Filings
- 20 days ago - Genelux Slides: Corporate presentation - Filings
- 2 months ago - Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer - GlobeNewsWire